{"nct_id":"NCT02798211","title":"Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2016-06-27","start_date_type":"ACTUAL","primary_completion_date":"2018-12-05","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-05","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}